Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium Channels in Working Memory Impairments of Chronic Cocaine Users
NCT07532460Recruiting
- Start
- May 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dalfampridine in cocaine use disorder (CUD) and cognitive impairment (2 arms). Primary endpoint: Global Working Memory Performance. Started May 2026; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
cocaine use disorder (CUD)cognitive impairment
Beyond the preview
Go deeper on NCT07532460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532460.